These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28142043)

  • 1. Initiators and promoters for the occurrence of screen-detected breast cancer and the progression to clinically-detected interval breast cancer.
    Yen AM; Wu WY; Tabar L; Duffy SW; Smith RA; Chen HH
    J Epidemiol; 2017 Mar; 27(3):98-106. PubMed ID: 28142043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and tumor characteristics of interval cancers by mammographic density.
    Holm J; Humphreys K; Li J; Ploner A; Cheddad A; Eriksson M; Törnberg S; Hall P; Czene K
    J Clin Oncol; 2015 Mar; 33(9):1030-7. PubMed ID: 25646195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers.
    Li J; Holm J; Bergh J; Eriksson M; Darabi H; Lindström LS; Törnberg S; Hall P; Czene K
    Ann Oncol; 2015 Mar; 26(3):517-22. PubMed ID: 25488685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.
    Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
    Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program.
    Baré M; Torà N; Salas D; Sentís M; Ferrer J; Ibáñez J; Zubizarreta R; Sarriugarte G; Barata T; Domingo L; Castells X; Sala M
    Breast Cancer Res Treat; 2015 Nov; 154(2):403-15. PubMed ID: 26531756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk assessment of multistate progression of breast tumor with state-dependent genetic and environmental covariates.
    Wu YY; Yen MF; Yu CP; Chen HH
    Risk Anal; 2014 Feb; 34(2):367-79. PubMed ID: 24111840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.
    Chuang SL; Chen SL; Yu CP; Chang KJ; Yen AM; Chiu SY; Fann JC; Tabár L; Stephen DW; Smith RA; Chen HH
    APMIS; 2014 Aug; 122(8):699-707. PubMed ID: 25046200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program.
    Kirsh VA; Chiarelli AM; Edwards SA; O'Malley FP; Shumak RS; Yaffe MJ; Boyd NF
    J Natl Cancer Inst; 2011 Jun; 103(12):942-50. PubMed ID: 21540443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAM50 and Risk of Recurrence Scores for Interval Breast Cancers.
    Puvanesarajah S; Nyante SJ; Kuzmiak CM; Chen M; Tse CK; Sun X; Allott EH; Kirk EL; Carey LA; Perou CM; Olshan AF; Henderson LM; Troester MA
    Cancer Prev Res (Phila); 2018 Jun; 11(6):327-336. PubMed ID: 29622545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammographic density and survival in interval breast cancers.
    Eriksson L; Czene K; Rosenberg LU; Törnberg S; Humphreys K; Hall P
    Breast Cancer Res; 2013 Jun; 15(3):R48. PubMed ID: 23786804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Use of Screening Mammography in Older Women Initiating Metformin versus Sulfonylurea.
    Hong JL; Henderson LM; Jonsson Funk M; Lund JL; Buse JB; Pate V; Stürmer T
    Pharmacoepidemiol Drug Saf; 2017 Jun; 26(6):666-675. PubMed ID: 28370798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year risk of interval-invasive second breast cancer.
    Lee JM; Buist DS; Houssami N; Dowling EC; Halpern EF; Gazelle GS; Lehman CD; Henderson LM; Hubbard RA
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25904721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of breast cancers detected by ultrasound screening in women with negative mammograms.
    Bae MS; Han W; Koo HR; Cho N; Chang JM; Yi A; Park IA; Noh DY; Choi WS; Moon WK
    Cancer Sci; 2011 Oct; 102(10):1862-7. PubMed ID: 21752153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical-pathologic characteristics and outcomes of true interval and screen-detected invasive breast cancer among participants of a Canadian breast screening program: a nested case-control study.
    Rayson D; Payne JI; Abdolell M; Barnes PJ; MacIntosh RF; Foley T; Younis T; Burns A; Caines J
    Clin Breast Cancer; 2011 Mar; 11(1):27-32. PubMed ID: 21421519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening.
    Chiu SY; Duffy S; Yen AM; Tabár L; Smith RA; Chen HH
    Cancer Epidemiol Biomarkers Prev; 2010 May; 19(5):1219-28. PubMed ID: 20406961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the transition from screen-film to digital screening mammography on interval cancer characteristics and treatment - a population based study from the Netherlands.
    Nederend J; Duijm LE; Louwman MW; Coebergh JW; Roumen RM; Lohle PN; Roukema JA; Rutten MJ; van Steenbergen LN; Ernst MF; Jansen FH; Plaisier ML; Hooijen MJ; Voogd AC
    Eur J Cancer; 2014 Jan; 50(1):31-9. PubMed ID: 24275518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biennial versus annual mammography and the risk of late-stage breast cancer.
    White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
    J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMI and breast cancer prognosis benefit: mammography screening reveals differences between normal weight and overweight women.
    Crispo A; Grimaldi M; D'Aiuto M; Rinaldo M; Capasso I; Amore A; D'Aiuto G; Giudice A; Ciliberto G; Montella M
    Breast; 2015 Feb; 24(1):86-9. PubMed ID: 25466863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammography features for early markers of aggressive breast cancer subtypes and tumor characteristics: A population-based cohort study.
    Tan PS; Ali MA; Eriksson M; Hall P; Humphreys K; Czene K
    Int J Cancer; 2021 Mar; 148(6):1351-1359. PubMed ID: 32976625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.